TOLERACELL Trademark

Trademark Overview

On Friday, March 11, 2022, a trademark application was filed for TOLERACELL with the United States Patent and Trademark Office. The USPTO has given the TOLERACELL trademark a serial number of 97307429. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Thursday, September 19, 2024. This trademark is owned by Diabetes Free, Inc. The TOLERACELL trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for medical use for regulating the immune system
toleracell

General Information

Serial Number97307429
Word MarkTOLERACELL
Filing DateFriday, March 11, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateThursday, September 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2024

Trademark Statements

Goods and ServicesBiological preparations for medical use for regulating the immune system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDiabetes Free, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10019
Party NameDiabetes Free, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10019

Trademark Events

Event DateEvent Description
Tuesday, March 15, 2022NEW APPLICATION ENTERED
Wednesday, March 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 22, 2022ASSIGNED TO EXAMINER
Thursday, January 5, 2023NON-FINAL ACTION WRITTEN
Thursday, January 5, 2023NON-FINAL ACTION E-MAILED
Thursday, January 5, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 4, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, April 4, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, July 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 26, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 26, 2023SUSPENSION LETTER WRITTEN
Wednesday, July 26, 2023LETTER OF SUSPENSION E-MAILED
Monday, March 4, 2024FINAL REFUSAL E-MAILED
Wednesday, February 7, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, March 4, 2024FINAL REFUSAL WRITTEN
Monday, March 4, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, May 31, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, May 31, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 31, 2024EXAMINERS AMENDMENT E-MAILED
Friday, May 31, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 31, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, July 9, 2024PUBLISHED FOR OPPOSITION
Wednesday, June 19, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, August 8, 2024EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, September 18, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

Related Keywords

toleracell immune system regulating medical preparations biological